Key result
Being seen by a cardiologist and arriving during the nightshift significantly reduced door-to-needle time for thrombolytic therapy in AMI patients (P=0.014 and P=0.034, respectively).
Why the study?
What are the factors that delay the administration of thrombolytic therapy in patients with acute myocardial infarction?
Population
146 patients diagnosed with acute myocardial infarction who received thrombolytic therapy at a general…
Design
Cohort
Authors
Loading...
Cardiologist evaluation and nightshift arrival were associated with shorter door-to-needle times; leaves open whether targeted staffing improves thrombolysis in AMI.
Cohort (n=146)
No
What are the factors that delay the administration of thrombolytic therapy in patients with acute myocardial infarction?
Delays in seeking medical care and obtaining an initial ECG significantly prolong door-to-needle times for thrombolysis in AMI patients, highlighting areas for process improvement.
Müller et al. (2008) conducted a cohort in Acute myocardial infarction (n=146). Delay factors (transport method, shift, specialty) was evaluated on Door-to-needle time. Being seen by a cardiologist and arriving during the nightshift significantly reduced door-to-needle time for thrombolytic therapy in AMI patients (P=0.014 and P=0.034, respectively).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: